Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Professor of Medicine
The Johns Hopkins Medical Institutions
Baltimore, Maryland

Topics of Professional Interest:
  • Hepatitis C virus and hepatitis B virus infections in HIV-infected persons
Current Professional Summary:

Dr Thomas is a Professor of Medicine at Johns Hopkins Medical Institutions.

Committees and Organizations:
  • American Society for Clinical Investigation
  • American Association for the Study of Liver Diseases
  • Infectious Diseases Society of America-HIV Medicine Association
Honors and Awards:
  • American Society for Clinical Investigation
  • The John Hopkins University Clinical Investigator
  • West Virginia University, Chemistry BA (1982)
  • West Virginia University School of Medicine, MD (1986)
  • The John Hopkins School of Hygiene and Public Health, MPH (1992)
  • Wake Forest University School of Medicine, Intern in Medicine (1986-1987)
  • Wake Forest University School of Medicine, Resident in Medicine (1987-1989)
  • The John Hopkins University School of Medicine, Fellow in Infectious Diseases (1990-1993)
Selected Publications:
  1. Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL. HLA-Cw*04 and hepatitis C virus persistence. J Virol. 2002;76:4792-4797.
  2. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL; Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921-1926.
  3. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002;288:199-206.
  4. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. Protection against persistence of hepatitis C. Lancet. 2002;359:1478-1483.
  5. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected patient. Clin Liver Dis. 2003;7:179-194.
  6. Pandey JP, Astemborski J, Thomas DL. Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus. J Virol. 2004;78:4561-4565.
  7. Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, Wang XH, Ray SC, Thomas DL. Cross-genotype immunity to hepatitis C virus. J Virol. 2004;78:1575-1581.
  8. Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, O'Brien SJ, Astemborski J, Thomas DL. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol. 2004;78:11258-11262.
  9. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004;305:872-874.


Advances in the Clinical Management of HIV Disease and Hepatitis C Virus Infection

Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes

An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management

Hepatitis C Virus (HCV) Infection: Looking Beyond the Interferon Alfa Era

An Advanced CME Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management